MedTrace Logo

Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care

NCT01516528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2017-09-20

No results posted yet for this study

Summary

This is a prospective, observational, non-drug interventional, non-randomized study to compare the rate of moderate-severe COPD exacerbations in patients of all Chronic Obstructive Pulmonary Disease (COPD) severities with and without cardiovascular diseases. A total study population of 3330 subjects will be recruited by general practitioners (GPs) and assessed over a 27 month time frame.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

PROCEDURE

Spirometry

Assessment of lung function by spirometry

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-17
Primary Completion
2015-05-01
Completion
2015-06-12

Countries

  • Belgium
  • France
  • Germany
  • Netherlands
  • Poland
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01516528 on ClinicalTrials.gov